Ligand validation:2VEK

CIT: CITRIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2VEK_CIT_B_1251	53%	25%	0.163	0.924	1.21	1.8	-	2	0	0	100%	1
2VEK_CIT_A_1251	45%	35%	0.184	0.916	1.15	1.39	-	3	0	0	100%	1
2VEN_CIT_B_1251	65%	32%	0.152	0.953	1	1.66	-	1	0	0	100%	1
3GVE_CIT_B_501	100%	24%	0.036	0.988	1.53	1.57	3	3	0	0	100%	1
6UAM_CIT_D_202	100%	33%	0.042	0.993	1.1	1.54	-	3	0	0	100%	0.93
3RJU_CIT_A_391	99%	38%	0.04	0.978	1.07	1.34	-	2	0	0	100%	1
4LQB_CIT_B_201	99%	40%	0.041	0.979	1.13	1.19	-	1	0	0	100%	1
1HHU_CIT_A_1015	99%	7%	0.058	0.994	1.64	3.19	2	9	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.